Review of long-term immunogenicity following HPV vaccination

Autor: TM Schurink-van 't Klooster, Hella Pasmans, R. Donken, J Hoes, H.E. de Melker, F.R.M. van der Klis, Johannes Berkhof

Publikováno v: Hoes, J, Pasmans, H, Schurink-van 't Klooster, T M, van der Klis, F R M, Donken, R, Berkhof, J & de Melker, H E 2021, ' Review of long-term immunogenicity following HPV vaccination : Gaps in current knowledge ', Human Vaccines & Immunotherapeutics, pp. 1-11 . https://doi.org/10.1080/21645515.2021.1908059

The licensed HPV vaccines are highly efficacious and induce high levels of neutralizing antibody levels, the assumed mediators of protection. However, a correlate of protection against HPV is lacking, and the evidence is still limited as to long-term

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae2b5a618b7d78fae7f5b9dce6e3618
https://doi.org/10.1080/21645515.2021.1908059

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands

Autor: TM Schurink-van 't Klooster, H.E. de Melker, Reinier Akkermans, A. C. de Munter, A. van Lier, Wilhelmina L.M. Ruijs

Publikováno v: BMC Public Health, 21
BMC Public Health, 21, 1
BMC Public Health, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Public Health

Background In the Netherlands, the HPV-vaccine uptake was 52% during the 2009 catch-up campaign (birth cohorts 1993–1996). This increased to 61% in the regular immunization program (birth cohorts 2000–2001). However for birth cohorts 2003–2004

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c194fea01cc5fd36f37b4e1c62e06ab8
https://doi.org/10.1186/s12889-021-11897-0

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands.

Autor: Schurink-van 't Klooster TM; Department National Immunisation Programme, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Siebers AG; PALGA, Houten, The Netherlands., Hoes J; Department National Immunisation Programme, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., van Kemenade FJ; Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands., Berkhof J; Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Bogaards JA; Department National Immunisation Programme, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Melker HE; Department National Immunisation Programme, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Publikováno v: Cancer medicine [Cancer Med] 2023 May; Vol. 12 (10), pp. 11786-11794. Date of Electronic Publication: 2023 Mar 25.

Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.

Autor: Woestenberg PJ; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Care and Public Health Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands., Guevara Morel AE; Department of Health Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health Research Institute, Amsterdam, The Netherlands., Bogaards JA; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Amsterdam, The Netherlands., Hooiveld M; Nivel, Utrecht, The Netherlands., Schurink-van 't Klooster TM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Hoebe CJPA; Care and Public Health Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Sexual Health, Infectious Diseases and Environment, South Limburg Public Health Service, Heerlen, The Netherlands., van der Sande MAB; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.; Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands., van Benthem BHB; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 15; Vol. 73 (2), pp. 291-297.

Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.

Autor: Schurink-van 't Klooster TM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: tessa.schurink@rivm.nl., Donken R; Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.; Women's Health Research Institute, BC Women's Hospital + Health Centre, University of British Colombia, Vancouver, BC, Canada., Schepp RM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., van der Klis FRM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., de Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Publikováno v: Vaccine [Vaccine] 2018 Nov 26; Vol. 36 (49), pp. 7580-7587. Date of Electronic Publication: 2018 Oct 28.